Gelonghui, January 22丨Peijia Medical-B (09996.HK) announced that on January 19, 2024 and January 22, 2024, Zhang Yi (“Zhang Yi”, Chairman and Executive Director) and the company's senior management used their own capital to acquire certain shares of the company from the market at a total cost of HK$768,000.
As Zhang Yi and senior management informed, the increase in shares was based on their full confidence in the company's product development, and further acquisition of shares in accordance with laws and regulations at the appropriate time was not ruled out.